Regional brain chemical alterations in young children with autism spectrum disorder

Neurology

Volumn 60, Issue 1, 2003, Pages 100-107

  Friedman, S D ^a   Shaw, D W ^a   Artru, A A ^a   Richards, T L ^a   Gardner, J ^a   Dawson, G ^a   Posse, S ^a   Dager, S R ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE; CREATININE; INOSITOL; N ACETYLASPARTIC ACID;

ARTICLE; AUTISM; BRAIN LEVEL; CHILD DEVELOPMENT; CLINICAL ARTICLE; DEVELOPMENTAL DISORDER; FEMALE; HUMAN; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; QUANTITATIVE ASSAY; SPECTROSCOPY;

EID: 0037435538     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.60.1.100     Document Type: Article

References (53)

1. Dawson G, Meltzoff AN, Osterling J, Rinaldi J. Neuropsychological correlates of early symptoms of autism. Child Dev 1998;69:1276-1285.
2. Rapin I, Katzman R. Neurobiology of autism. Ann Neurol 1998;43:7-14.
3. Minshew NJ, Dombrowski SM. In vivo neuroanatomy of autism: neuroimaging studies. In: Bauman ML, Kemper TL, eds. The neurobiology of autism. Baltimore: Johns Hopkins University Press, 1994;67-85.
4. Piven J, Arndt S, Bailey J, Havercamp S, Andreasen NC, Palmer P. An MRI study of brain size in autism. Am J Psychiatry 1995;152:1145-1149.
5. Courchesne E, Karns CM, Davis HR, et al. Unusual brain growth patterns in early life in patients with autistic disorder: an MRI study. Neurology 2001;57:245-254.
6. Zilbovicius M, Garreau B, Samson Y, Remy P. Delayed maturation of the frontal cortex in childhood autism. Am J Psychiatry 1995;152:248-252.
7. Ohinishi T, Matsuda H, Hashimoto T, et al. Abnormal regional cerebral blood flow in childhood autism. Brain 2000;123:1838-1844.
8. Ryu YH, Lee JD, Yoon PH, Kim DI, Lee HB, Shin YJ. Perfusion impairments in infantile autism on technetium-99m ethyl cysteinate dimer brain single-photon emission tomography: comparison with findings on magnetic resonance imaging. Eur J Nucl Med 1999;26:253-259.
9. Muller R, Chugani DC, Behen ME, et al. Impairment of dentatothalamo-cortical pathway in autistic men: language activation data from positron emission tomography. Neuroscience 1998;245:1-4.
10. Siegel BV Jr, Asarnow R, Tanguay P, et al. Regional cerebral glucose metabolism and attention in adults with a history of childhood autism. J Neuropsychiatry Clin Neurosci 1992;4:406-414.
11. Sparks BF, Friedman SD, Shaw DW, et al. Brain structural abnormalities in young children with autism spectrum disorder. Neurology 2002;59:184-192.
12. Bauman ML, Kemper TL. Histoanatomic observations of the brain in early infantile autism. Neurology 1985;35:866-874.
13. Bailey A, Luther P, Dean A, et al. Clinicopathological study of autism. Brain 1998;121:889-905.
14. Bauman ML, Kemper TL. Neuroanatomic observations of the brain in autism. In: Bauman ML, Kemper TL, eds. The neurobiology of autism. Baltimore: Johns Hopkins University Press, 1994;119-145.
15. Ross B, Michaelis T. Clinical applications of magnetic resonance spectroscopy. Magn Reson Med 1994;10:191-247.
16. Friedman SD, Brooks WM, Jung RE, et al. Quantitative proton MRS predicts outcome after traumatic brain injury. Neurology 1999;52:1384-1391.
17. Friedman SD, Brooks WM, Stidley CA, Hart BL, Sibbitt WL Jr. Brain injury and neurometabolic abnormalities in systemic lupus erythematosus. Radiology 1998;209:79-84.
18. Dager SR, Steen RG. Applications of MRS to the investigation of neuropsychiatric disorders. Neuropsychopharmacology 1992;6:249-266.
19. Kyoon Lyoo I, Renshaw PF. Magnetic resonance spectroscopy: current and future applications in psychiatric research. Biol Psychiatry 2002;51:195-207.
20. 1H NMR spectroscopic studies of brain. Neurosci Biobehav Rev 1989;13:23-31.
21. Bhakoo KK, Pearce D. In vitro expression of N-acetyl aspartate by oligodendrocytes: implications for proton magnetic resonance spectroscopy signal in vivo. J Neurochem 2000;74:254-262.
22. Baslow MH. Functions of N-acetyl-l-aspartate and N-acetyl-laspartylglutamate in the vertebrate brain: role in glial cell-specific signaling. J Neurochem 2000;75:453-459.
23. Coyle JT, Schwarcz R. Mind glue: implications of glial cell biology for psychiatry. Arch Gen Psychiatry 2000;57:90-93.
24. Kreis R, Ernst T, Ross BD. Development of the human brain: in vivo quantification of metabolite and water content with proton magnetic resonance spectroscopy. Magn Reson Med 1993;30:424-437.
25. Bluml S, Seymour KJ, Ross BD. Developmental changes in choline- and ethanolamine-containing compounds measured with proton-decoupled (31)P MRS in vivo human brain. Magn Reson Med 1999;42:643-654.
26. Moore CM, Breeze JL, Kukes TH, et al. Effects of myo-inositol ingestion on human brain myo-inositol levels: a proton magnetic resonance spectroscopic imaging study. Biol Psychiatry 1999;45:1197-1202.
27. Friedman SD, Dager SR, Richards TL, Petropoulos H, Posse S. Dynamic brain metabolism quantified by internal water reference: a feasibility study. Psychiatry Res Neuroimaging 2000;8:55-66.
28. Tsacopoulos M, Magistretti PJ. Metabolic coupling between glia and neurons. J Neurosci 1996;16:877-885.
29. Chih C, Lipton P, Roberts EL. Do active cerebral neurons really use lactate rather than glucose? Trends Neurosci 2001;24:573-578.
30. Posse S, Dager SR, Richards TL, et al. In vivo measurement of regional brain metabolic response to hyperventilation using functional proton echo-planar spectroscopic imaging (PEPSI). Magn Reson Med 1997;37:858-865.
31. Dager SR, Layton ME, Strauss W, et al. Human brain metabolic response to caffeine and the effects of tolerance. Am J Psychiatry 1999;156:229-237.
32. Dager SR, Friedman SD, Heide A, et al. Two-dimensional proton echoplanar spectroscopic imaging (PEPSI) of brain metabolic changes during lactate-induced panic. Arch Gen Psychiatry 1999;56:70-77.
33. 1H MRS in vivo. Magn Reson Med 1999;41:193-197.
34. Lord C, Rutter M, Le Couteur A. Autism Diagnostic Interview-Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord 1994;24:659-685.
35. Lord C, Risi S, Lambrecht L, et al. The autism diagnostic observational schedule generic: a standard measure of social and communication deficits associated with the spectrum of autism. J Autism Dev Disord 2000;30:205-224.
36. Mullen P. Mullen Scales of Early Learning. Circle Pines, MN: American Guidance Service, 1984.
37. Sparrow SS, Balla DA, Cichetti DV. Vineland Adaptive Behavior Scales: survey form manual. Circle Pines, MN: American Guidance Service, 1984.
38. Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993;30:672-679.
39. Provencher SW. LcModel and LcMgui user's manual. Available at: http://s-provencher.com/pages/lcm-manual.shtml. Accessed January 19, 2000.
40. Sled JG, Zijdenbos AP, Evans AC. A nonparametric method for automatic correction of intensity nonuniformity in MRI data. Trans Med Imaging 1998;17:98-97.
41. Bowman C, Shaprio M. A multiscale model for Bayesian image segmentation. Trans Image Processing 1994;3:162-177.
42. Barker PT, Soher BJ, Blackband SJ, Chatham JC, Mathews VP, Bryan RN. Quantitation of proton NMR spectra of the human brain using tissue water as an internal concentration reference. NMR Biomed 1994;6:89-94.
43. Kimura H, Fujii Y, Itoh S, et al. Metabolic alterations in the neonate and infant brain during development: evaluation with proton MR spectroscopy. Radiology 1995;194:483-489.
44. Chugani DC, Sundram BS, Behen M, Lee ML, Moore GJ. Evidence of altered energy metabolism in autistic children. Prog Neuropsychopharmacol Biol Psychiatry 1999;23:635-641.
45. Hashimoto T, Tayama M, Miyazaki M, et al. Differences in brain metabolites between patients with autism and mental retardation as detected by in vivo localized proton magnetic resonance spectroscopy. J Child Neurol 1997;12:91-96.
46. Hashimoto T, Kawano N, Fukuda K, et al. Proton magnetic resonance spectroscopy of the brain in three cases of Rett syndrome: comparison with autism and normal controls. Acta Neurol Scand 1998;98:8-14.
47. 1H-MR spectroscopy study. Pediatr Neuroradiol 1999;41:517-519.
48. Hisaoka S, Harada M, Nishitani H, Mori K. Regional magnetic resonance spectroscopy of the brain in autistic individuals. Neuroradiology 2001;43:496-498.
49. Artru AA. Propofol combined with halothane or with fentanylhalothance does not alter the rate of CSF formation or resistance to reabsorbtion of CSF in rabbits. J Neurosurg Anesthesiol 1994;5:250-257.
50. Sakabe T, Nakakimura K. Effects of anesthetic agents and other drugs on cerebral blood flow, metabolism, and intracranial pressure. In: Cottrell JE, Smith DS, eds. Anesthesia and neurosurgery. St. Louis: Mosby, 2001;129-143.
51. Zhu XH, Chen W. Observed BOLD effects on cerebral metabolite resonances in human visual cortex during visual stimulation: a functional (1)H MRS study at 4 T. Magn Reson Med 2001;46:841-847.
52. Lundbom NM, Manner T, Komu M, Peltola O, Leino KA, Kirvela OA. Barbiturate anesthesia and brain proton spectroscopy. Am J Neuroradiol 1999;20:1543-1546.
53. Casanova MF, Buxhoeveden DP, Switala AE, Roy E. Minicolumnar pathology in autism. Neurology 2002;58:428-432.